NEW DELHI: As many as 11,300 'Made in India' ventilators have been dispatched so far and 6,154 have been delivered to the hospitals, said Dr Harsh Vardhan, Union Minister for Health and Family Welfare. "So far, 11,300 'Make In India' ventilators have been dispatched; 6,154 delivered to hospitals. Ministry of Health is also supplying 1.02 lakh oxygen cylinders across India; 72,293 delivered," Dr Harsh Vardhan tweeted on Saturday. "Over 6.12 crore HCQ (Hydroxychloroquine) tablets distributed," read an infographic shared by Dr. Harsh Vardhan. India on Friday reported its highest single-day spike of COVID-19 cases with 22,771 cases reported in the last 24 hours, said the Union Ministry of Health and Family Welfare. With these new cases, India's coronavirus cases tally
NEW DELHI: Prime Minister Narendra Modi on Tuesday lamented the increase in negligence in personal and social behaviour since 'Unlock-1' from June one when coronavirus lockdown curbs were eased, and said no one is above law in India be it a village pradhan or the head of the government. In his address to the nation, the Prime Minister also observed that rules were followed very strictly during the nationwide lockdown imposed on March 25, adding there is a need to be alert and more careful during the 'Unlock 2.0' phase. Here are the top developments: 1 India PM Modi said that during the unlock phase, governments, local bodies and people need to show alertness. "We especially need to
SEOUL: South Korea has added Gilead's anti-viral drug remdesivir to its coronavirus treatment guidelines in its first revision of recommendations since the outbreak began and urged caution in the use of the steroid therapy dexamethasone. South Korea, widely praised around the world for its handling of the pandemic without a full lockdown, has reported 12,602 coronavirus cases as of Thursday midnight, with 282 deaths. Remdesivir is designed to hinder certain viruses, including the new coronavirus, from making copies of themselves and potentially overwhelming the body's immune system. The drug previously failed trials as an Ebola treatment. South Korea's updated guidelines come after a study showed that the cheap and widely used dexamethasone reduced deaths in very sick Covid-19 patients. They
GENEVA/LONDON: The World Health Organization said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit. "The hydroxychloroquine arm of the SOLIDARITY trial has been stopped," WHO expert Ana Maria Henao-Restrepo told a news briefing.
NEW DELHI: As the number of Covid-19 cases crossed the three lakh-mark, the government on Saturday came out with a revised treatment protocol to deal with the deadly infection, allowing use of antiviral drug Remdesivir in moderate cases and Hydroxychloroquine in patients during the early course of the disease. It also recommended an off-label application of Tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma for treating coronavirus-infected patients in moderate stage of the illness, besides adding loss of smell or taste to the list of Covid-19 symptoms. In its revised 'Clinical Management Protocols for Covid-19', the Union health ministry, in a turnaround from its earlier decision, advised use of the anti-malarial drug hydroxychloroquine
NEW DELHI: Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday that the study related to the anti-malarial drug, which suspended the drug usage, is not a randomised clinical trial and rather only an analysis of hospital registers around the world. The WHO, on Sunday, announced for a temporary suspension of clinical trials of hydroxychloroquine, which has been used for the treatment of COVID-19 patients, after a study published in the online medical journal The Lancet found that the use of the drug increased the risk of death by 34 per cent
नई दिल्ली: कोरोना वायरस (Coronavirus) महामारी के इलाज में पहली बार भारत ने विश्व स्वास्थ्य संगठन (WHO) के सुझावों को ठुकरा दिया है. कोरोना वायरस फैलने में WHO की लापरवाही पर दुनियाभर में किरकिरी होने के बावजूद भारत इस मामले में चुप रहा है. लेकिन कोरोना वायरस के इलाज में WHO के नए सुझावों को इस बार देश के वैज्ञानिकों ने सिरे से नकार दिया है. हाइड्रोक्सीक्लोरोक्वीन पर WHO की सलाह को मानने से किया इंकारकोरोना वायरस के इलाज में हाइड्रोक्सीक्लोरोक्वीन (Hydroxychloroquine) की दवा के इस्तेमाल को लेकर WHO ने शंका जताई है. साथ ही कहा है कि ये दवा कोरोना वायरस के इलाज लिए सुरक्षित नहीं है. लेकिन इस बार भारत ने अपना कड़ा रुख अपना लिया है. भारतीय आयुर्विज्ञान
NEW DELHI: Lockdown, timely identification and management of Covid-19 cases in the country has kept the number of deaths restricted to 0.3 per lakh of the total population while the world average stands at 4.4 per lakh population, according to the ministry of health. The ministry informed that 6,535 more coronavirus cases have been reported in India in the last 24 hours, taking the total number of Covid-19 cases to 1,45,380 with 4,167 deaths. Here are the top developments: 1 India The Union ministry of health said that the recovery rate of Covid-19 cases in India has been improving considerably. A total of 60,490 patients have recovered so far from Covid-19. The recovery rate continues to improve and
NEW DELHI: No major side-effects of Hydroxychloroquine (HCQ) have been found in studies in India and its use should be continued in preventive treatment for Covid-19, the Indian Council of Medical Research (ICMR) said on Tuesday. The ICMR's statement came against the backdrop of the World Health Organization (WHO) suspending the testing of the drug in Covid-19 patients temporarily in its global study following safety concerns. "The Covid-19 is an evolving field and we do not know which drug is working and which is not working. Lot of drugs are being repurposed for Covid-19, whether for prophylaxis or for treatment of Covid-19. "We found there were no major side affects except for nausea, vomiting, palpitation occasionally. Hence in our advisory
NEW DELHI: A revised government advisory has recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-Covid-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities. As was mentioned in the earlier advisory, the drug against the infection is also recommended for all asymptomatic healthcare workers involved in containment and treatment of Covid-19 and household contacts of laboratory confirmed cases. The revised advisory issued by the ICMR on Friday, however, cautioned that the intake of the medicine should not instill a sense of false security. The recommendation was made after the Joint Monitoring Group under the Chairmanship of Directorate General of Health Services (DGHS) and including
NEW DELHI: In an important decision, the health ministry on Friday revised its advisory on use of hydroxychloroquine (HCQ) as a prophylactic for Covid-19 infection, expanding the drug’s use for asymptomatic healthcare and frontline workers deployed in Covid and non-Covid areas. As per the fresh advisory, issued after ICMR conducted tests on the use of the medicine, all asymptomatic healthcare workers involved in containment, such as Asha workers, municipal employees and police, those treating Covid-19 patients and asymptomatic healthcare workers working in non-Covid hospitals or non-Covid areas of such hospitals or blocks, are now eligible for prophylactic use of HCQ. The advisory said caution must be exercised in case of people with cardio rhythm disorders and hypersensitivity to the drug.
वाशिंगटन: अमेरिकी राष्ट्रपति डोनाल्ड ट्रंप (Donald Trump) अपने बारे में कुछ सुनना नहीं चाहते, फिर चाहे वह सलाह ही क्यों न हो. हाल ही में हाउस स्पीकर नैंसी पेलोसी (Nancy Pelosi) ने उन्हें मलेरिया-रोधी दवा हाइड्रोक्सीक्लोरोक्वीन (Hydroxychloroquine) का इस्तेमाल न करने की सलाह दी थी, जिसके जवाब में राष्ट्रपति ने उन्हें मानसिक रूप से बीमार कहा है. ट्रंप ने कहा कि नैंसी मानसिक समस्याओं से घिरी हुईं बीमार महिला हैं. दरअसल, सोमवार को डोनाल्ड ट्रंप ने यह स्वीकार किया था कि वह अपनी ही सरकार की चेतावनियों के बावजूद कोरोना वायरस (Coronavirus) से बचाव के लिए मलेरिया की दवा ले रहे हैं. इसके बाद उनकी जमकर आलोचना हुई. नैंसी पेलोसी ने भी उन पर निशाना साधा, साथ ही उन्होंने ट्रंप को
NEW DELHI: An interim report prepared by the Telangana government has yielded promising results on the efficacy of prophylactic use of Hydroxychloroquine or HCQ, as it is popularly known, on preventing COVID-19 in frontline medical workers in the state. Over 70 per cent of healthcare workers in the Telangana Government study who were administered the malarial drug on a trial basis to prevent against Covid-19 infection reported no onset of symptoms that were linked to the SARS-Cov-2 (Covid-19) viral infection. 394 (73.9 percent) healthcare workers who could potentially have contact with Covid-19 patients remained asymptomatic after ingesting HCQ and appeared to display strong immune responses to the Coronavirus. In addition to this, 71% out of these 394 frontline health care
NEW DELHI: President Donald Trump's declaration that he was taking a malaria drug of dubious effectiveness to help fend off the coronavirus will likely be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring the world's largest producer of the drug to make much more of it, prescribe it for front-line health workers treating the virus and deploy it as a diplomatic tool, despite mounting evidence against using the drug for Covid-19. Trump said Monday that he was taking hydroxychloroquine as a measure of protection against the virus. The U.S. Food and Drug Administration, however, has cautioned against using it outside of hospitals because of the risk of serious heart problems.
NEW DELHI: India has so far about 0.2 Covid-19 deaths per lakh population as against the global figure of 4.1, the Union health ministry said as the number of fatalities due to coronavirus infection in the country rose to 3,163 on Tuesday and the total cases reached 1,01,139. Referring to data from the WHO situation report-119, the ministry said 3,11,847 Covid-19 mortalities have been reported till Tuesday worldwide which is about 4.1 deaths per lakh population. Here are the top developments: 1 India A record number of 1,08,233 samples were tested for Covid-19 in the country. So far a total of 24,25,742 samples have been tested, the Union health ministry said. The Centre issued a Standard Operating Protocol
नई दिल्ली: संपूर्ण लॉकडाउन (Lockdown) के बाद भी भारत अपनी दवा की खेप आइसलैंड तक पहुंचने में कामयाब रहा. 25,000 रोगियों के इलाज के लिए पर्याप्त मलेरिया की दवा क्लोरोक्वीन के 50,000 पैकेट भारत द्वारा भेजे गए. आइसलैंड की राजधानी रेकजाविक से हमारे प्रमुख राजनयिक संवाददाता सिद्धांत सिब्बल से बात करते हुए, आइसलैंड में भारत के राजदूत आर्मस्ट्रांग चांगसन ने कहा कि कैसे आइसलैंड की डिकोडे जेनेटिक्स और भारत की CSIR-IGIB महामारी पर हो रही रिसर्च में सहयोग करने के लिए तरीकों और साधनों की जांच कर रहे हैं.आर्मस्ट्रांग ने वहां फंसे हुए भारतीयों के बारे में भी बात की, जिनकी संख्या लगभग 10 है और भारतीय मिशन यह सुनिश्चित करने की कोशिश कर रहा है कि वे किसी भी
ढाका: कोरोना वायरस (coronavirus) महामारी से लड़ने में भारत ने पड़ोसी देश बांग्लादेश की भी मदद की है. रविवार को भारत ने बांग्लादेश को हाइड्रोक्सीक्लोरोक्वीन की एक लाख गोलियां और 50,000 सर्जिकल दस्ताने दिए हैं. बता दें कि बांग्लादेश में अब तक कोरोना वायरस संक्रमण के करीब 5,000 मामले सामने आए हैं और 140 लोगों की मौत हुई है. भारत की उच्चायुक्त रीवा गांगुली दास ने बांग्लादेश को मेडिकल सहायता की दूसरी खेप भेजे जाने के मौके पर भारत-बांग्लदेश संबंधों के महत्व को बताते हुए नोबेल पुरस्कार से सम्मानित कवि रविंद्रनाथ टैगोर का जिक्र किया. दास ने हाइड्रोक्सीक्लोरोक्वीन की एक लाख गोलियां और 50,000 सर्जिकल दस्ताने सहित चिकित्सा सामग्री बांग्लादेश के स्वास्थ्य मंत्री जाहिद मलिक को सौंपे. मंत्री ने कहा, ‘‘संकट की इस घड़ी